abstract |
The present invention also relates to the use of an antibody according to Kabat, Chothia or the EU numbering system for HC-F404, HC-K121, HC-Y180, HC-F241, HC-221, LC-T22, LC- K42, LC-E161, LC-D170, HC-S136, HC-S25, HC-A40, HC-S119, HC-S190, HC-K222, HC-R19, HC-Y52 or HC-S70 An antibody conjugate having binding specificity to CD74, a composition such as a pharmaceutical composition comprising the antibody conjugate, a method for producing the antibody conjugate, and a method for producing the antibody conjugate and composition, And the like. |